Emerging viral infections of the central nervous system: Part 1

Archives of Neurology

Volumn 66, Issue 8, 2009, Pages 939-948

  Tyler, Kenneth L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FOSCARNET SODIUM; GANCICLOVIR; IMMUNOGLOBULIN; JAPANESE ENCEPHALITIS VACCINE; ORAL POLIOMYELITIS VACCINE; PLACEBO; RIBAVIRIN;

ARBOVIRUS; CENTRAL NERVOUS SYSTEM INFECTION; CHIKUNGUNYA ALPHAVIRUS; CLINICAL FEATURE; CLINICAL TRIAL; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; EPIDEMIC; EPIDEMIC ENCEPHALITIS; HENDRA VIRUS; HOST RANGE; HOST RESISTANCE; HUMAN; HUMAN HERPESVIRUS 6; INFECTION RISK; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MONKEYPOX; MONKEYPOX VIRUS; NIPAH VIRUS; NONHUMAN; ORGAN TRANSPLANTATION; PARANEOPLASTIC NEUROPATHY; POLIOMYELITIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RABIES; RABIES VIRUS; REVIEW; TOSCANA VIRUS; VACCINATION; VIRUS MENINGITIS; WEST NILE FLAVIVIRUS;

ANIMALS; ANIMALS, WILD; ARTHROPOD VECTORS; CENTRAL NERVOUS SYSTEM INFECTIONS; COMMUNICABLE DISEASES, EMERGING; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; GREENHOUSE EFFECT; HUMANS; RISK; VIRUS DISEASES; WORLD HEALTH; ZOONOSES;

EID: 68549121126     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.153     Document Type: Review

References (76)

1. Olival KJ, Daszak P. The ecology of emerging neurotropic viruses. J Neurovirol. 2005;11(5):441-446.
2. Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990-993.
3. Taylor LH, Latham SM, Woolhouse MEJ. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 2001;356(1411):983-989.
4. Patz JA, Campbell-Lendrum D, Holloway T, Foley JA. Impact of regional climate change on human health. Nature. 2005;438(7066):310-317.
5. Wild poliovirus weekly update. Global Polio Eradication Initiative Web site. http: //www.polioeradication.org/casecount.asp. Accessed May 1, 2009.
6. Stewardson AJ, Roberts JA, Beckett CL, et al. Imported case of poliomyelitis, Melbourne, Australia, 2007. Emerg Infect Dis. 2009;15(1):63-65.
7. Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356-359.
8. Estívariz CF, Watkins MA, Handoko D, et al. A large vaccine-derived poliovirus outbreak on Madura Island-Indonesia, 2005. J Infect Dis. 2008;197(3):347-354.
9. Rakoto-Andrianarivelo M, Gumede N, Jegouic S, et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis. 2008; 197(10):1427-1435.
10. Alexander JP, Ehresmann K, Seward J, et al; Vaccine-Derived Poliovirus Investigations Group. Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis. 2009;199(3):391-397.
11. Arboviral encephalitis cases reported in humans, by type, United States, 1964-2007. CDC Web site. http://www.cdc.gov/ncidod/dvbid/arbor/arbocase.htm. Accessed February 1, 2009.
12. Reisen WK, Fang Y, Brault AC. Limited interdecadal variation in mosquito (Diptera: Culicidae) and avian host competence for Western equine encephalomyelitis virus (Togaviridae: Alphavirus). Am J Trop Med Hyg. 2008;78(4):681-686.
13. Forrester NL, Kenney JL, Deardorff E, Wang E, Weaver SC. Western equine encephalitis submergence: lack of evidence for a decline in viral virulence. Virology. 2008;380(2):170-172.
14. Eldridge BF, Glaser C, Pedrin RE, Chiles RE. The first reported case of California encephalitis in more than 50 years. Emerg Infect Dis. 2001;7(3):451-452.
15. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med. 2001;344(11):801-807.
16. Nash D, Mostashari F, Fine A, et al; 1999 West Nile Outbreak Response Working Group. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344(24):1807-1814.
17. West Nile virus. CDC Web site. http://www.cdc.gov/ncidod/dvbid/westnile/ index.htm. Accessed February 1, 2009.
18. Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Emerg Infect Dis. 2007;45(8):1039-1046.
19. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 1999;286(5448):2333-2337.
20. Lanciotti RS, Ebel GD, Deubel V, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology. 2002;298(1):96-105.
21. Jia X-Y, Briese T, Jordan I, et al. Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet. 1999;354(9194):1971-1972.
22. Giladi M, Metzkor-Cotter E, Martin DA, et al. West Nile encephalitis in Israel in 1999, the New York connection. Emerg Infect Dis. 2001;7(4):659-661.
23. Peterson AT, Vieglais DA, Andreasen JK. Migratory birds modeled as critical transport agents for West Nile virus in North America. Vector Borne Zoonotic Dis. 2003; 3(1):27-37.
24. Rappole JH, Compton BW, Leimgruber P, Robertson J, King DI, Renner SC. Modeling movement of West Nile virus in the Western hemisphere. Vector Borne Zoonotic Dis. 2006;6(2):128-139.
25. Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003; 9(3):311-322.
26. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353(5):451-459.
27. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis. 2008;198(7):984-993.
28. Platt KB, Tucker BJ, Halbur PG, et al. Fox squirrels (Sciurus niger) develop West Nile virus viremias sufficient for infecting select mosquito species. Vector Borne Zoonotic Dis. 2008;8(2):225-233.
29. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11(8):1174-1179.
30. Davis LE, DeBiasi RL, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol. 2006;60(3):286-300.
31. Debiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nat Clin Pract Neurol. 2006;2(5):264-275.
32. Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16(4):209-224.
33. Kramer LD, Li J, Shi PY. West Nile virus. Lancet Neurol. 2007;6(2):171-181.
34. Beckham D, Tyler KL. Clinical manifestations of neurological disease. In: Diamond MS, ed. West Nile Encephalitis Virus Infection. New York, NY: Springer; 2009:69-95.
35. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis. 2006;42(9):1234-1240.
36. Murray K, Baraniuk S, Resnick M, et al. Risk factors of encephalitis and death from West Nile virus infection. Epidemiol Infect. 2006;134(6):1325-1332.
37. Yakub I, Lillibridge KM, Moran A, et al. Single nucleotide polymorphisms in genes for 2'-5′-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis. 2005;192(10):1741-1748.
38. Glass WG, McDermott DH, Lim JK, et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med. 2006;203(1):35-40.
39. Tyler KL, Pape J, Goody RJ, Corkill M, Kleinschmidt-DeMasters BK. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66(3):361-365.
40. Ali M, Safriel Y, Sohi J, Llave A, Weathers S. West Nile virus infection:MRimaging findings in the nervous system. AJNR Am J Neuroradiol. 2005;26(2):289-297.
41. Petropoulou KA, Gordon SM, Prayson RA, Ruggierri M. West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol. 2005;26(8): 1986-1995.
42. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11(7):1021-1027.
43. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis. 2006;12(3):514-516.
44. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C. Evaluation of immunoglobulinM( IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J Clin Microbiol. 2000;38(6):2232-2239.
45. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis. 2003;9(3):376-379.
46. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet. 2003;361(9360): 821-826.
47. Charrel RN, Gallian P, Navarro-Mari J-M, et al. Emergence of Toscana virus in Europe. Emerg Infect Dis. 2005;11(11):1657-1663.
48. Di Nicuolo G, Pagliano P, Battisti S, et al. Toscana virus central nervous system infections in southern Italy. J Clin Microbiol. 2005;43(12):6186-6188.
49. Dionisio D, Valassina M, Ciufolini MG, et al. Encephalitis without meningitis due to sandfly fever virus serotype Toscana. Clin Infect Dis. 2001;32(8):1241-1243.
50. Baldelli F, Ciufolini MG, Francisci D, et al. Unusual presentation of lifethreatening Toscana virus meningoencephalitis. Clin Infect Dis. 2004;38(4): 515-520.
51. Solomon T. Control of Japanese encephalitis-within our grasp? N Engl J Med. 2006;355(9):869-871.
52. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present and future of Japanese encephalitis. Emerg Infect Dis. 2009;15(1):1-7.
53. Ooi MH, Lewthwaite P, Lai BF, et al. The epidemiology, clinical features, and longterm prognosis of Japanese encephalitis in central Sarawak, Malaysia 1997-2005. Clin Infect Dis. 2008;47(4):458-468.
54. Kumar R, Tripathi P, Baranwal M, Singh S, Tripathi S, Banerjee G. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India [published online ahead of print January 14, 2009]. Clin Infect Dis. doi: 10.1086/596309.
55. Tauber E, Dewasthaly S. Japanese encephalitis vaccines-needs, flaws and achievements. Biol Chem. 2008;389(5):547-550.
56. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44(5):646-656.
57. McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236-242.
58. Pérez-Vélez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.Clin Infect Dis. 2007;45(8):950-957.
59. Dolin R. Enterovirus 71: emerging infections and emerging questions. N Engl J Med. 1999;341(13):984-985.
60. Cardosa MJ, Krishnan S, Tio PH, Perera D, Wong SC. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet. 1999;354(9183):987-991.
61. Yang KD, Yang MY, Li CC, et al. Altered cellular but not humoral reactions in children with complicated enteroviral 71 infections in Taiwan. J Infect Dis. 2001; 183(6):850-856.
62. 2007 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2007.
63. Fishman JA. Infection in solid organ transplant recipients. N Engl J Med. 2007; 357(25):2601-2614.
64. Iwamoto M, Jernigan DB, Guasch A, et al; West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348(22):2196- 2203.
65. Burton EC, Burns DK, Opatowsky MJ, et al. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol. 2005;62(6):873-882.
66. Srinivasan A, Burton EC, Kuehnert MJ, et al; Rabies in Transplant Recipients Investigation Team. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med. 2005;352(11):1103-1111.
67. Fischer SA, Graham MB, Kuehnert MJ, et al; LCMV in Transplant Recipients Investigation Team. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med. 2006;354(21):2235-2249.
68. Palacios G, Druce J, Du L, et al. A new arenavirus in a cluster of fatal transplantassociated diseases. N Engl J Med. 2008;358(10):991-998.
69. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis. 1995;21(3):571-576.
70. Isaacson E, Glaser CA, Forghani B, et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis. 2005; 40(6):890-893.
71. Yao K, Honarmand S, Espinosa A, Akhyani N, Glaser C, Jacobson S. Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol. 2009;65(3):257-267.
72. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med. 1994;330(19):1356-1360.
73. Wainwright MS, Martin PL, Morse RP, et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol. 2001;50(5):612-619.
74. Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69(2):156-165.
75. Provenzale JM, vanLandingham KE, Lewis DV, Mukundan S Jr, White LE. Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging. Radiology. 2008;249(3):955-963.
76. Tunkel AR, Glaser CA, Bloch KC, et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-327.